ICON will manage Eli Lilly’s clinical trial site setup and monitoring in Europe. This arrangement follows Lilly’s selection of ICON to manage its clinical data management business outside the U.S., which was announced in November 2008.

Previous articleReimbursing Molecular Diagnostics
Next articleDendrite Formation and Maintenance Require Two Proteins